Search Results
Results found for "Zhou Y"
- 📰 GPCR Weekly News, April 17 to 23, 2023
Submit your interest in giving a talk or presenting a poster to Hello@DrGPCR.com. Don't miss out! Below is your Classified GPCR News at a glance for April 17 to 23, 2023.
- 📰 GPCR Weekly News, April 10 to 16, 2023
Are you ready for some exciting news in the GPCR world? Then check this out 👓! Now you can submit your job opening and offer a position in an exclusive GPCR community around the globe While the program is being finalized, if you're interested in giving a talk or presenting a poster, please Below is your Classified GPCR News at a glance for April 10 to 16, 2023.
- 📰 GPCR Weekly News, April 3 to 9, 2023
Also, please mark your calendar for the next Dr. The program is under construction but if you’d like to give a talk or present a poster, email us at Hello @DrGPCR.com Below is your Classified GPCR News at a glance for April 3rd to 9th, 2023.
- 📰 GPCR Weekly News, March 27 to April 4, 2023
Hello Readers👋, This week in the GPCR news we have collected the most up-to-date news for you. Also, please mark your calendar for the next Dr. The program is under construction but if you’d like to give a talk or present a poster, email us at Hello @DrGPCR.com Below is your Classified GPCR News at a glance for March 27th to April 4th, 2023. with curriculum and deep reinforcement learning Structure Therapeutics Reports Fourth Quarter and Full Year
- 📰 GPCR Weekly News, March 20 to 26, 2023
Hello Readers👋, We're excited to have you in the Dr. GPCR Ecosystem. Every week, we send you the most relevant news, research, and advancements in the field. For Dr. Below is your Classified GPCR News at a glance for March 20th to 26th, 2023. Exscientia Business and Financial Update for the Full Year 2022.
- 📰 GPCR Weekly News, March 13 to 19, 2023
We thrive to keep you up-to-date with everything happening in the world of GPCR. Remember, you can always adjust your email preferences in your account settings. For Dr. If you'd like to present a poster, please submit yours today. There is still time. There is no limit to the number of posters we can accommodate, so hurry and submit your poster so that Below is your Classified GPCR News at a glance for March 13th to 19th, 2023.
- 📰 GPCR Weekly News, March 6 to 12, 2023
Hello Readers👋, Thank you for being here with us this week. We work tirelessly to bring you informative and exciting news about the world of GPCR every Thursday. Are you ready for our first Dr. GPCR Symposium event held on March 24th? If you'd like to present a poster, please submit yours today. Below is your Classified GPCR News at a glance for March 6th to 12th, 2023.
- 📰 GPCR Weekly News, February 27 to March 5, 2023
Keep in mind that you can always change your email preferences in your account settings. We are excited to welcome you to the first Dr. GPCR Symposium event held on March 24th. If you'd like to present a poster, please submit yours today. There is no limit to the number of posters we can accommodate, so hurry and submit your poster so that Below is your Classified GPCR News at a glance for February 27th to March 5th, 2023.
- 📰 GPCR Weekly News, February 20 to 26, 2023
Hello Readers👋, Thank you for joining us this week. Each week on Thursday, you receive informative and exciting news about GPCRs. If you'd like to suggest papers to include in our news, please email them to us at Hello@DrGPCR.com. Below is your Classified GPCR News at a glance for February 20th to 26th, 2023. GPCR Therapeutics on Beyond Biotech Podcast Crinetics Pharmaceuticals Reports Fourth Quarter And Full Year
- 📰 GPCR Weekly News, February 13 to 19, 2023
Remember, you can always adjust your email preferences in your account settings. If you'd like to suggest papers to include in our news, please email them to us at Hello@DrGPCR.com. Below is your Classified GPCR News at a glance for February 13th to 19th, 2023.
- 📰 GPCR Weekly News, February 6 to 12, 2023
Hello Readers👋, We're excited to share our weekly newsletter with you. with the latest research and advancements in the field with our convenient, weekly news delivered to your You can always adjust your email preferences in your account settings. For Dr. Below is your Classified GPCR News at a glance for February 6th to 12th, 2023.
- New role of β-arrestins in MOR signaling
If you are interested in learning more about the molecular details of this study, you can consult the
- 📰 GPCR Weekly News, January 30 to February 5, 2023
Hello Readers👋, We're excited to share our weekly newsletter with you. with the latest research and advancements in the field with our convenient, weekly news delivered to your You can always adjust your email preferences in your account settings. For Dr. GPCR News, please subscribe to your monthly newsletter. Below is your Classified GPCR News at a glance for January 30th to February 5th, 2023.
- 📰 GPCR Weekly News, January 23 to 29, 2023
Hello Readers👋, We're excited to share our weekly newsletter with you. with the latest research and advancements in the field with our convenient, weekly news delivered to your You can always adjust your email preferences in your account settings Below is your Classified GPCR News
- 📰 GPCR Weekly News, January 16 to 22, 2023
Hello Readers👋, We're excited to share our weekly newsletter with you. with the latest research and advancements in the field with our convenient, weekly news delivered to your You can always adjust your email preferences in your account settings Below is your Classified GPCR News
- Odorant receptors – a bit of smell for drug discovery
odorant molecules which initiate a neuronal response that drives odorant discrimination and perception (Young
- 📰 GPCR Weekly News - January 2 to 8, 2023
Hello Readers👋, We're excited to share our weekly newsletter with you. with the latest research and advancements in the field with our convenient, weekly news delivered to your You can always adjust your email preferences in your account settings. Below is your Classified GPCR News at a glance for January 2nd to January 8th, 2023.
- 📰 GPCR Weekly News
Hello Readers👋, Happy New Year! We're excited to be back and share our weekly newsletter! We'll be sending it directly to your inbox every week, so you'll always be the first to know about the Below is your Classified GPCR News at a glance for December 19th to January 1st, 2023. Industry News Sosei Heptares and Neurocrine Biosciences won Out-Licensing Deal of the Year from Locust
- 📰 GPCR Weekly News
Hello Readers👋, We are working on bringing your the latest GPCR News more frequently directly in your Below is your Classified GPCR News at a glance for December 12 to December 18th, 2022.
- 📰 GPCR Weekly News
Hello Readers👋, Get the latest GPCR News more frequently directly in your inbox and in the Ecosystem Below is your Classified GPCR News at a glance for December 5 to December 11th, 2022.
- 📰 GPCR Weekly News
Hello Readers👋, We are working on bringing your the latest GPCR News more frequently directly in your Below is your Classified GPCR News at a glance for November 28 to December 4th, 2022. Mechanisms underlying divergent relationships between Ca2+ and YAP/TAZ signaling. Virtual screening yields refined GPCR agonists.
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
Additionally, structural analysis of the TM5 and TM6 regions of 27 class A GPCRs coupled to Gs or Gi/o yielded
- Ode to GPCRs
Every year, with the month of October, comes the excitement of the Nobel session to the global scientific Ye, R. D. Regulation of nuclear factor κB activation by G-protein-coupled receptors.
- Case Report of a Juvenile Patient with Autism Spectrum Disorder with a Novel Combination of Copy...
ADGRL3 (LPHN3) and Two Pseudogenes "We report the finding of two copy number variants (CNVs) in a 12-year-old
- Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C...
Additionally, using the Gαq/11 inhibitor YM-254890, GPCR kinase 2 and 3 (GRK2 and GRK3) KO cells, and
- Comparative studies of AlphaFold, RoseTTAFold and Modeller: a case study involving the use of...
receptors "Neural network (NN)-based protein modeling methods have improved significantly in recent years
- Single-molecule counting applied to the study of GPCR oligomerization
These details are often challenging to quantitatively assess yet are essential for our understanding
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
greatly impact the treatment of CVD with unprecedented benefits which will be revealed in the next years
- Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused...
AHH who shared characteristics with the 2 cases we previously reported as follows: (a) elderly (74-87 years
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
2022 "Cannabinoid Receptor 2 (CB2) is a G protein-coupled receptor (GPCR) with considerable, though as yet


